论文部分内容阅读
目的探讨肥厚性梗阻性心肌病的经皮室间隔心肌化学消融术治疗疗效。方法选取肥厚型梗阻性心肌病患者(2009年3月至2010年3月)22例,运用经皮室间隔心肌化学消融术对其进行治疗,术后行为期半年的回访,定期对患者进行心电图及超声心动图复查。结果术后患者的病症、体征与超声心动图较术前均有显著改善,肥厚的室间隔心肌均变薄,无严重并发症。结论经皮室间隔心肌化学消融术治疗肥厚型梗阻性心肌病可取得较好的临床疗效,在无重大过失情况下,手术安全、可靠。
Objective To investigate the efficacy of percutaneous transcatheter myocardial chemical ablation of hypertrophic obstructive cardiomyopathy. Methods Twenty-two patients with hypertrophic obstructive cardiomyopathy (March 2009 to March 2010) were enrolled in this study. They were treated by transcatheter interventricular septal myocardial chemical ablation, and were followed up for six months after operation. The electrocardiogram And echocardiography review. Results The postoperative patients’ symptoms, signs and echocardiography were significantly improved compared with that before operation. The hypertrophic ventricular septum became thinner without serious complications. Conclusion Transcatheter transcatheter myocardial chemical ablation for the treatment of hypertrophic obstructive cardiomyopathy can achieve better clinical curative effect, without serious fault, the operation is safe and reliable.